Anti-HIV activity of stilbene-related heterocyclic compounds

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 15, 2006, Pages 4075-4079

  Bedoya, Luis M ^a   del Olmo, Esther ^b   Sancho, Rocío ^c   Barboza, Bianca ^b   Beltrán, Manuela ^a   García Cadenas, Ana E ^b   Sánchez Palomino, Sonsoles ^a   López Pérez, José L ^b   Muñoz, Eduardo ^c   Feliciano, Arturo San ^b   Alcamí, José ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Benzalphthalides; HIV replication; Imidazoisoindoles; NF B; Phthalazinones; Pyrimidoisoindoles; Tat

Indexed keywords

ANTIVIRUS AGENT; BENZALPHTHALIDE; HETEROCYCLIC COMPOUND; IMIDAZOINDOLE; IMIDAZOLE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLE DERIVATIVE; PHTHALAZINE DERIVATIVE; PHTHALAZINONE; PHTHALIC ACID DERIVATIVE; PYRIMIDOISOINDOLE DERIVATIVE; STILBENE DERIVATIVE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG SYNTHESIS; FEMALE; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; PROTEIN FUNCTION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANTI-HIV AGENTS; GENE PRODUCTS, TAT; HELA CELLS; HETEROCYCLIC COMPOUNDS; HIV LONG TERMINAL REPEAT; HUMANS; NF-KAPPA B; STILBENES;

EID: 33745154884     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.04.087     Document Type: Article

References (25)

1. WHO epidemiological report 2004. UNAIDS 2004.
2. Rabson A.B., and Lin H.C. Adv. Pharmacol. 48 (2000) 161
3. Pande V., and Ramos M.J. Curr. Med. Chem. 10 (2003) 1603
4. Rohr O., Marban C., Aunis D., and Schaeffer E. J. Leukocyte Biol. 74 (2003) 736
5. Rabson A.B., and Lin H.C. Adv. Pharm. 48 (2000) 161
6. Gatignol A., and Jeang K.T. Adv. Pharmacol. 48 (2000) 209
7. Gatignol A., Duarte M., Daviet L., Chang Y.N., and Jeang K.T. Gene Expr. 5 (1996) 217
8. Rosen C.A., and Pavlakis G.N. AIDS 4 (1990) A5
9. Marciniak R.A., Calnan B.J., Frankel A.D., and Sharp P.A. Cell 63 (1990) 791
10. Alcami J., Lain de Lera T., Folgueira L., Pedraza M.A., Jacque J.M., Bachelerie F., Noriega A.R., Hay R.T., Harrich D., and Gaynor R.B. EMBO J. 14 (1995) 1552
11. Coiras M., Camafeita E., Ureña T., López J.A., Caballero F., Fernández B., López-Huertas M.R., Pérez-Olmeda M., and Alcamí. Proteomics 6 (2006) 563
12. De Clercq E. Clin. Microbiol. Rev. 8 (1995) 200
13. Stevenson M. Nat. Med. 9 (2003) 163
14. Yeni P.G., Hammer S.M., Carpenter C.C., Cooper D.A., Fischl M.A., Gatell J.M., Gazzard B.G., Hirsch M.S., Jacobsen D.M., Katzenstein D.A., Montaner J.S., Richman D.D., Saag M.S., Schechter M., Schooley R.T., Thompson M.A., Vella S., and Volberding P.A. J. Am. Med. Assoc. (JAMA) 288 (2002) 222
15. Karin M., Yamamoto Y., and Wang Q.M. Nat. Rev. Drug Disc. 3 (2004) 17
16. Wang L.X., Heredia A., Song H., Zhang Z., Yu B., Davis C., and Redfield R. J. Pharm. Sci. 93 (2004) 2448
17. Dai J.R., Hallock Y.F., Cardellina II J.H., and Boyd M.R. J. Nat. Prod. 61 (1998) 351
18. Hamy F., Gelus N., Zeller M., Lazdins J.L., Bailly C., and Klimkait T. Chem. Biol. 7 (2000) 669
19. Del Olmo E., García-Armas M., López-Pérez J.L., Muñoz V., Deharo E., and San Feliciano A. Bioorg. Med. Chem. Lett. 11 (2001) 2123
20. Del Olmo E., García-Armas M., López-Pérez J.L., Ruiz G., Vargas F., Giménez A., Deharo E., and San Feliciano A. Bioorg. Med. Chem. Lett. 11 (2001) 2755
21. Del Olmo E., García-Armas M., Ybarra M.I., López-Pérez J.L., Oporto P., Giménez A., Deharo E., and San Feliciano A. Bioorg. Med. Chem. Lett. 13 (2003) 2769
22. Del Olmo E., Barboza B., Ybarra M.I., López-Pérez J.L., Carrón R., Sevilla M.A., Boselli C., and San Feliciano A. Bioorg. Med. Chem. Lett. 16 (2006) 2786
23. Zamilpa A., Herrera-Ruiz M., del Olmo E., López-Pérez J.L., Tortoriello J., and San Feliciano A. Bioorg. Med. Chem. Lett. 15 (2005) 3483
24. Garcia et al. Unpublished.
25. Marquez N., Sancho R., Macho A., Calzado M.A., Fiebich B.L., and Muñoz E.J. Pharmacol. Exp. Ther. 308 (2004) 993